SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-000018
Filing Date
2021-01-04
Accepted
2021-01-04 07:06:14
Documents
12
Period of Report
2021-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K brhc10018576_8k.htm   iXBRL 8-K 34539
  Complete submission text file 0001140361-21-000018.txt   178052

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA myov-20210103.xsd EX-101.SCH 4192
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE myov-20210103_lab.xml EX-101.LAB 23345
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myov-20210103_pre.xml EX-101.PRE 16673
5 EXTRACTED XBRL INSTANCE DOCUMENT brhc10018576_8k_htm.xml XML 4378
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37929 | Film No.: 21500139
SIC: 2834 Pharmaceutical Preparations